Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolic pathway-based subtyping reveals distinct microenvironmental states associated with diffuse large B-cell lymphoma outcomes.

Hematological oncology - 1 Jul 2024

Wang Xiaohui, Liu Hengqi, Fei Yue, Song Zheng, Meng Xiangrui, Yu Jingwei, Liu Xia, Li Lanfang, Qiu Lihua, Qian Zhengzi, Zhou Shiyong, Wang Xianhuo, Zhang Huilai

Abstract excerpt

Diffuse large B-cell lymphoma (DLBCL) is a biologically and clinically heterogeneous disease that requires personalized clinical treatment. Assigning patients to different risk categories and cytogenetic abnormality and genetic mutation groups has been widely applied for prognostic stratification of DLBCL. Increasing evidence has demonstrated that dysregulated metabolic processes contribute to the initiation and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Gene Expression Profiling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphoma, Large B-Cell, Diffuse

Share to Metabolic Networks and Pathways

Share to Mutation

Share to Prognosis

Share to Tumor Microenvironment

Source

Identifiers

PMID: 38819002
DOI: 10.1002/hon.3279

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolic pathway-based subtyping reveals distinct microenvironmental states associated with diffuse large B-cell lymphoma outcomes.PMID 38819002Read ↗

Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signatureSemantic proximity Read ↗

Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signatureSemantic proximity Read ↗

A novel molecular classification of diffuse large B cell lymphoma based on Metabolism-related genesSemantic proximity Read ↗

Identification of a prognostic metabolic gene signature in diffuse large B‐cell lymphomaSemantic proximity Read ↗

Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancersSemantic proximity Read ↗

A Pan-Cancer Atlas of Metabolic Regulatory Circuitries Integrating Multi-Omic, Immune, and Clinical DimensionsSemantic proximity Read ↗

Identification of a 16-MTGs Prognostic Signature in Diffuse large B-cell lymphomaSemantic proximity Read ↗

Identified lung adenocarcinoma metabolic phenotypes and their association with tumor immune microenvironment.Semantic proximity Read ↗

Metabolic predictors of response to immune checkpoint blockade therapySemantic proximity Read ↗

Metabolic predictors of response to immune checkpoint blockade therapySemantic proximity Read ↗

Exploring the role of metabolic pathways in TNBC immunotherapy: insights from single-cell and spatial transcriptomicsSemantic proximity Read ↗

Glucose Metabolic Reprogramming in Cancer MicroenvironmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.